Common variants associated with plasma triglycerides and risk for coronary artery disease

@article{Do2013CommonVA,
  title={Common variants associated with plasma triglycerides and risk for coronary artery disease},
  author={Ron Do and Cristen J. Willer and Ellen M. Schmidt and Sebanti Sengupta and Chi Gao and Gina M. Peloso and Stefan Gustafsson and Stavroula Kanoni and Andrea Ganna and Jin Chen and Martin L Buchkovich and Samia Mora and Jacques S. Beckmann and Jennifer L. Bragg-Gresham and Hsing-Yi Chang and Ayşe Demirkan and Heleen M. den Hertog and Louise Donnelly and Georg B. Ehret and T{\~o}nu Esko and Mary F. Feitosa and Teresa Ferreira and Krista Fischer and Pierre Fontanillas and Ross M Fraser and Daniel F. Freitag and Deepti Gurdasani and Kauko Heikkil{\"a} and Elina Hypp{\"o}nen and Aaron Isaacs and Anne U. Jackson and {\AA}sa Johansson and Toby Johnson and Marika A Kaakinen and Johannes Kettunen and Marcus E. Kleber and Xiaohui Li and Jian’an Luan and Leo-Pekka Lyytik{\"a}inen and Patrik K. E. Magnusson and Massimo Mangino and Evelin Mihailov and May E. Montasser and Martina M{\"u}ller-Nurasyid and Ilja M. Nolte and Jeffrey R. O'Connell and Cameron Palmer and Markus Perola and Ann-Kristin Petersen and Serena Sanna and Richa Saxena and Susan K. Service and Sonia Shah and Dmitry Shungin and Carlo Sidore and Ci Song and Rona J. Strawbridge and Ida Surakka and Toshiko Tanaka and Tanya M. Teslovich and Gudmar Thorleifsson and Evita G. van den Herik and Benjamin F. Voight and Kelly A. Volcik and Lindsay L. Waite and Andrew Wong and Ying Wu and Weihua Zhang and Devin M Absher and Gershim Asiki and In{\^e}s Barroso and Latonya Been and Jennifer L. Bolton and Lori L Bonnycastle and Paolo Brambilla and Mary Susan Burnett and Giancarlo Cesana and Maria Dimitriou and Alex S. F. Doney and Angela D{\"o}ring and Paul Elliott and Stephen E. Epstein and Gudmundur Ingi Eyjolfsson and Bruna Gigante and Mark O. Goodarzi and Harald Grallert and Martha L. Gravito and Christopher J. Groves and Göran Hallmans and A-L. Hartikainen and Caroline Hayward and Dena G Hernandez and Andrew A. Hicks and Hilma H{\'o}lm and Yi-Jen Hung and Thomas Illig and Michelle R Jones and Pontiano Kaleebu and John J. P. Kastelein and Kay-Tee Khaw and Eric S. Kim and Norman Klopp and Pirjo Komulainen and Meena Kumari and Claudia Langenberg and Terho Lehtim{\"a}ki and Shih-Yi Lin and Jaana Lindstr{\"o}m and Ruth J. F. Loos and François Mach and Wendy L McArdle and Christa Meisinger and Braxton D. Mitchell and Gabrielle M{\"u}ller and Ramaiah Nagaraja and Narisu Narisu and Tuomo V M Nieminen and Rebecca N. Nsubuga and Isleifur Olafsson and Ken K. Ong and Aarno Palotie and Theodore Papamarkou and Cristina Pomilla and Anneli Pouta and Daniel J. Rader and Muredach P. Reilly and Paul M. Ridker and Fernando Rivadeneira and Igor Rudan and Aimo O Ruokonen and Nilesh J. Samani and Hubert Scharnagl and Janet Seeley and Kaisa Silander and Alena Stan{\vc}{\'a}kov{\'a} and Kathleen E. Stirrups and Amy J. Swift and Laurence Tiret and Andr{\'e} G. Uitterlinden and Lucas Joost Van Pelt and Sailaja Vedantam and Nicholas W. J. Wainwright and Cisca Wijmenga and Sarah H. Wild and Gonneke Willemsen and Tom Wilsgaard and James F. Wilson and Elizabeth H. Young and Jing Hua Zhao and Linda S Adair and Dominique Arveiler and Themistocles L. Assimes and Stefania Bandinelli and Franklyn I. Bennett and Murielle Bochud and Bernhard Otto Boehm and Dorret I. Boomsma and Ingrid B. Borecki and Stefan R. Bornstein and Pascal Bovet and Michel Burnier and Harry Campbell and Aravinda Chakravarti and John Campbell Chambers and Yii-Der I. Chen and Francis S. Collins and Richard S. Cooper and John Danesh and George V. Dedoussis and Ulf de Faire and Alan B. Feranil and Jean Ferri{\`e}res and Luigi Ferrucci and Nelson B. Freimer and Christian Gieger and Leif C Groop and Vilmundur G. Gudnason and Ulf Gyllensten and Anders Hamsten and Tamara B. Harris and Aroon D. Hingorani and Joel N. Hirschhorn and Albert Hofman and G. Kees Hovingh and Chao A. Hsiung and Steve E. Humphries and Steven C. Hunt and Kristian Hveem and Carlos Iribarren and Marjo-Riitta J{\"a}rvelin and Antti M Jula and Mika K{\"a}h{\"o}nen and Jaakko A. Kaprio and Antero Y. Kes{\"a}niemi and Mika Kivimaki and Jaspal S Kooner and Peter J. Koudstaal and Ronald M. Krauss and Diana Kuh and Johanna Kuusisto and Kirsten Ohm Kyvik and Markku Laakso and Timo A. Lakka and Lars Lind and Cecilia M. Lindgren and Nicholas G. Martin and Winfried M{\"a}rz and Mark I. McCarthy and Colin A Mckenzie and Pierre Meneton and Andres Metspalu and Leena Moilanen and Andrew D. Morris and Patricia B. Munroe and Inger Nj{\o}lstad and Nancy L. Pedersen and Christine Power and Peter P. Pramstaller and Jackie F. Price and Bruce M. Psaty and Thomas Quertermous and Rainer Rauramaa and Danish Saleheen and Veikko V Salomaa and Dharambir K. Sanghera and Jouko L. Saramies and Peter E H Schwarz and Wayne Huey-Herng Sheu and Alan R. Shuldiner and Agneta Siegbahn and Tim D. Spector and K{\'a}ri Stef{\'a}nsson and David P. Strachan and Bamidele O. Tayo and Elena Tremoli and Jaakko Tuomilehto and Matti Uusitupa and Cornelia M. van Duijn and Peter Vollenweider and Lars Wallentin and Nicholas J. Wareham and John B. Whitfield and Bruce H. R. Wolffenbuttel and David M Altshuler and Jos{\'e} M Ordov{\'a}s and Eric Boerwinkle and Colin N. A. Palmer and Unnur Thorsteinsd{\'o}ttir and Daniel I. Chasman and Jerome I. Rotter and Paul W. Franks and Samuli Ripatti and L. Adrienne Cupples and Manjinder S. Sandhu and Stephen S. Rich and Michael Boehnke and Panos Deloukas and Karen L. Mohlke and Erik Ingelsson and Gonçalo R. Abecasis and Mark J. Daly and Benjamin M. Neale and Sekar Kathiresan},
  journal={Nature genetics},
  year={2013},
  volume={45},
  pages={1345 - 1352}
}
Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery disease (CAD). However, it is unclear whether this association reflects causal processes. We used 185 common variants recently mapped for plasma lipids (P < 5 × 10−8 for each) to examine the role of triglycerides in risk for CAD. First, we highlight loci associated with both low-density lipoprotein… Expand
Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics.
TLDR
Genetic variants associated with plasma LDL-C levels are consistently associated with CAD risk in the right direction, consistent with a causal relationship, and similar studies have causally implicated the key TG-regulating enzyme lipoprotein lipase (LPL) in CAD risk. Expand
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
TLDR
Routinely measured lipid fractions exhibit contrasting associations with the risk of CAD and diabetes, and all 3 lipid traits were associated with a lower risk of type 2 diabetes. Expand
Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
TLDR
The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 × 10−8), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk. Expand
Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
TLDR
In patients with elevated triglycerides, several novel drugs are in development to reduce the residual risk on statin therapy linked to an excess of atherogenic triglyceride-rich lipoproteins. Expand
Genetics of Triglycerides and the Risk of Atherosclerosis
TLDR
The findings collectively shift the understanding towards a potential causal role for triglycerides, but one cannot rule out the possibilities that triglycerides are a component of a joint phenotype with low HDL-C or that they are but markers of deeper causal metabolic disturbances that are not routinely measured in epidemiological-scale genetic studies. Expand
Common variants associated with blood lipid levels do not affect carotid plaque composition.
TLDR
This study found no evidence that plasma lipid levels or their genetic determinants influence carotid plaque composition. Expand
Lipid-related genes and their associations with coronary heart disease
TLDR
The results suggest a BMI-gene interaction effect on CHD and suggest that the observational associations between dyslipidemia and chronic low-degree inflammation are more likely to be driven by other common causes such as adiposity. Expand
Discovery and Refinement of Loci Associated with Lipid Levels
TLDR
It is found that loci associated with blood lipid levels are often associated with cardiovascular and metabolic traits, including coronary artery disease, type 2 diabetes, blood pressure, waist-hip ratio and body mass index. Expand
Mining genomic variants and causal pathways linking HDL and triglycerides to coronary disease
TLDR
The findings suggest that HDL functionality in driving cholesterol removal through SR-BI (the reverse cholesterol transport hypothesis) is protective from CHD in humans, and provides a sampling of approaches for leveraging the spectrum of genomic methods to identify clinically relevant variants impacting HDL, TG and CHD risk. Expand
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
TLDR
Combined, these genetic results anticipate that, beyond low-density lipoprotein, pharmacological lowering of triglyceride-rich lipoproteins or lipop protein(a) will reduce risk for CHD, but this remains to be proven through randomized controlled trials. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids
TLDR
The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD. Expand
Discovery and Refinement of Loci Associated with Lipid Levels
TLDR
It is found that loci associated with blood lipid levels are often associated with cardiovascular and metabolic traits, including coronary artery disease, type 2 diabetes, blood pressure, waist-hip ratio and body mass index. Expand
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
TLDR
Data from a genetic variant that regulates triglyceride concentration are consistent with a causal association between triglyceride-mediated pathways and coronary heart disease. Expand
Remnant cholesterol as a causal risk factor for ischemic heart disease.
TLDR
A nonfasting remnant cholesterol increase of 1 mmol/l (39 mg/dl) is associated with a 2.8-fold causal risk for ischemic heart disease, independent of reduced HDL cholesterol, which implies that elevated cholesterol content of triglyceride-rich lipoprotein particles causes ischeMIC heart disease. Expand
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
TLDR
Low plasma LDL cholesterol levels robustly associated with increased risk of MI but genetically decreased HDL cholesterol did not, which may suggest that low HDL cholesterol levels per se do not cause MI. Expand
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.
TLDR
Clinicians are updated on the increasingly crucial role of triglycerides in the evaluation and management of CVD risk and highlight approaches aimed at minimizing the adverse public health–related consequences associated with hypertriglyceridemic states. Expand
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
TLDR
Mendelian randomisation analyses challenge the concept that raising of plasma HDL cholesterol will uniformly translate into reductions in risk of myocardial infarction. Expand
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
TLDR
Using genome-wide association data from three studies and targeted replication association analyses in up to 18,554 independent participants, it is shown that common SNPs at 18 loci are reproducibly associated with concentrations of low-density cholesterol, high-density lipoprotein (HDL) cholesterol, and/or triglycerides. Expand
Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
TLDR
Common genetic variation in APOA1 associated with increased apoA-I and HDL cholesterol levels did not associate with decreased risk of ischemic heart disease or MI. Expand
Common variants at 30 loci contribute to polygenic dyslipidemia
TLDR
The results suggest that the cumulative effect of multiple common variants contributes to polygenic dyslipidemia. Expand
...
1
2
3
4
5
...